CTS Research Consortium was established to further CTS’s leadership in infectious disease research. This collaboration between Vitalant Research Institute, Carter BloodCare, OneBlood, ITxM, New York Blood Center and Bloodworks Northwest will provide a wealth of data for the development of future hypothesis-based research studies.
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...